Colorectal Chemopreventives Should Show 30% Adenoma Reduction – Cmte.

Chemopreventive agents should show at least a 30% reduction in the number of precancerous adenomas to be associated with a benefit in colorectal cancer risk reduction, FDA's Gastrointestinal Drugs Advisory Committee suggested March 19